-1775582746855.png&w=3840&q=75)
compounded tirzepatide vial GLP-1/GIP Rx Compounded GLP-1 - Semaglutide &
Description
Pharmacological therapies have demonstrated substantial effects in weight loss, appetite suppression and modulation of foodrelated thoughts
The pen delivers doses of 1 mg
Even more concerning
Both activate GLP-1 receptors to reduce appetite and support metabolic changes
Data Availability This study involves the analysis of de-identified Electronic Health Record (EHR) data via the nference nSights Federated Clinical Analytics Platform (nSights)
